Ultrastructure of liver progenitor/oval cells in children with nonalcoholic steatohepatitis

Advances in Medical Sciences

Volumn 56, Issue 2, 2011, Pages 172-179

  Sobaniec Lotowska M E ^a   Lebensztejn, D M ^a   Lotowska J M ^a   Kanczuga Koda L ^b   Sulkowski, S ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Maria Sk odowska Curie Memorial Bialystok Oncology Center   (Poland)

Author keywords

children; liver fibrosis; liver progenitor oval cells; nonalcoholic steatohepatitis; ultrastructure

Indexed keywords

ADOLESCENT; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL ULTRASTRUCTURE; CHILD; CLINICAL ARTICLE; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KUPFFER CELL; LIVER BIOPSY; LIVER CELL; LIVER OVAL CELL; LIVER PROGENITOR CELL; MACROPHAGE; MALE; NONALCOHOLIC FATTY LIVER; PRESCHOOL CHILD; SCHOOL CHILD; STELLATE CELL; TISSUE SECTION;

EID: 84855457240     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-011-0037-8     Document Type: Article

References (53)

1. Ehrmann J, Strojil J. Current concepts and morphological aspects of drug induced liver injury. Cesk Patol. 2008 Jan;44(1):4-7.
2. Hesham A-Kader H. Nonalcoholic fatty liver disease in children living in the obeseogenic society. World J Pediatr. 2009 Nov;5(4):245-54.
3. Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol. 2009 Feb;24(2):248-54.
4. Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Obes Surg. 2005 Mar;15(3):442-6. (Pubitemid 40463617)
5. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005 Sep;42(3):641-9. (Pubitemid 41233657)
6. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008 Nov;28(4):370-9.
7. Byrne CD. Hypoxia and non-alcoholic fatty liver disease. Clin Sci (Lond). 2009 Dec 14;118(6):397-400.
8. Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, Sanyal AJ, Schwimmer JB, Lavine JE. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol. 2010 Sep;105(9):2093-102.
9. Lebensztejn DM, Kowalczuk D, Tarasów E, Skiba E, Kaczmarski M. Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD. Adv Med Sci. 2010 Jun;55(1):74-9.
10. Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: usefulness of electron microscopy in the diagnosis of the disease. Am J Gastroenterol. 2003 Jul;98(7):1664-5. (Pubitemid 36875372)
11. Caldwell SH, Patrie JT, Brunt EM, Redick JA, Davis CA, Park SH, Neuschwander-Tetri BA. The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis. Hepatology. 2007 Oct;46(4):1101-7. (Pubitemid 350144774)
12. Park KS, Jang BK, Chung WJ, Cho KB, Hwang JS, Ahn SH, Kang YN, Hwang JB, Keum DY. Abnormal electron microscopic fndings of nonalcoholic steatohepatitis and related factors. Korean J Gastroenterol. 2005 Jun;45(6):417-24.
13. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001 Apr;120(5):1183-92. (Pubitemid 32246672)
14. Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH. J Gastroenterol. 2004 Dec;39(12):1215-8. (Pubitemid 40074291)
15. Oliva J, French BA, Quing X, French SW. The identifcation of stem cells in human liver diseases and hepatocellular carcinoma. Exp Mol Pathol. 2010 Jun;88(3):331-40.
16. Salizzoni M, Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroentetrology. 2002 Jul;123(1):134-40. (Pubitemid 34747534)
17. Vial P, Riquelme A, Pizarro M, Solis N, Madariaga JA, Aguayo G, Duarte I, Soza A, Accatino L, Arrese M. Pentoxifylline does not prevent neither liver damage nor early profbrogenic events in a rat model of non-alcoholic steatohepatitis. Ann Hepatol. 2006 Jan-Mar;5(1):25-9.
18. de Lima VM, Oliveira CP, Alves VA, Chammas MC, Oliveira EP, Stefano JT, de Mello ES, Cerri GG, Carrilho FJ, Caldwell SH. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol. 2008 Dec;49(6):1055-61.
19. Roskams T, Yang SQ, Koteish A, Durnez A, De Vos R, Huang X, Achten R, Verslype C, Diehl AM. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol. 2003 Oct;163(4):1301-11. (Pubitemid 37175079)
20. Guettier C. Which stem cells for adult liver? Ann Pathol. 2005 Feb;25(1):33-44. (Pubitemid 40488412)
21. He ZP, Tan WQ, Tang YF, Zhang HJ, Feng MF. Activation, isolation, identifcation and in vitro proliferation of oval cells from adult rat livers. Cell Prolif. 2004 Apr;37(2):177-87. (Pubitemid 38429328)
22. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, Bussolati B, Camussi G. Isolation and characterization of a stem cell population from adult human liver. Stem Cells. 2006 Dec;24(12):2840-50. (Pubitemid 46053020)
23. Housset C. Biliary epithelium, hepatocytes and oval cells. Rev Prat. 2000 Dec; 50(19):2106-11.
24. Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochem Biophys Acta. 2008 Feb;1782(2):61-74.
25. Vessey CJ, de la Hall PM. Hepatic stem cells: a review. Pathology. 2001 May; 33(2):130-41 (Pubitemid 32453403)
26. Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy. Cell Tissue Res. 2008 Jan;331(1):271-82. (Pubitemid 350265492)
27. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006 Feb;43(2 Suppl 1):S45-53.
28. Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M, Feinstone SM, Thorgeirsson SS. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology. 2006 Dec; 44(6):1478-86. (Pubitemid 44953653)
29. Schaff Z, Nagy P. Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells. Orv Hetil. 2004 Aug 29;145(35):1787-93.
30. Parent R, Marion MJ, Furio L, Trepo C, Petit MA. Origin and characterization of human bipotent liver progenitor cell line. Gastroenterology. 2004 Apr;126(4):1147-56. (Pubitemid 38451185)
31. Sell S, Leffert HL. Liver cancer stem cells. J Clin Oncol. 2008 Jun;26(17):2800-5.
32. Uenishi T, Hirohashi K, Shuto T, Tsukamoto T, Yamamoto T, Ogawa M, Kubo S, Tanaka H, Kinoshita H. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers. Hepatogastroenterology. 2002 Jul-Aug;49(46):1092-4. (Pubitemid 34809795)
33. Zhang F, Chen XP, Zhang W, Dong HH, Xiang S, Zhang WG, Zhang BX. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fuorescence immunostaining evidence. Histopathology. 2008 Jan;52(2):224-32.
34. Roskams T, de Vos R, Van Eyken P, Myazaki H, Van Damme B, Desmet V. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol. 1998 Sep;29(3):455-63. (Pubitemid 28396664)
35. Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, Dixon JB, Weltman MD, Tilg H, Moschen AR, Purdie DM, Demetris AJ, Clouston AD. Progressive fbrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology. 2007 Jul;133(1):80-90. (Pubitemid 47031146)
36. Beath SV. Hepatic function and physiology in the newborn. Semin Neonatol. 2003 Oct;8(5):337-46. (Pubitemid 37237130)
37. Sobaniec-Lotowska ME, Lotowska JM, Lebensztejn DM. Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fbrosis: the frst pediatric study. World J Gastroenterol. 2007 Jun 7;13(21):2918-22. (Pubitemid 47028880)
38. Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. Electron microscopic alterations in intermediate hepatocyte-like cells in children with chronic hepatitis B: the frst report in pediatric patients. Eur J Gastroenterol Hepatol. 2010 Jun;22(6):741-7.
39. Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructure of the liver progenitor/oval cells in children with non-alcoholic steatohepatitis. The frst report in pediatric patients. Falk Symposium 176. Environment and Lifestyle-Effects on Disorders of the Digestive tract; 2010 Oct 9-10, Freiburg, Germany, 48 p.
40. Hashimoto E, Yatsujis S, Kaneda H, Yoshioka Y, Taniai M, Tokushige K, Shiratori K. The characteristics and nature history of Japanese patients with nonalcoholic fatty liver disease. Hepatol Res. 2005 Oct;33(2):72-6. (Pubitemid 41799778)
41. Dunn W, Schwimmer JB. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep. 2008 Feb;10(1):67-72.
42. Bartok I, Viragh S, Hegedus C, Bartok K. Ultrastructure of Ito cells in fbrotic liver disease. Morphol Igazsagugyi Orv Sz. 1989 Jan;29(1):18-29.
43. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofbroblast subpopulations in fbrotic human and rat livers. J Hepatol. 2002 Feb; 36(2):200-9. (Pubitemid 34146426)
44. Washington K, Wright K, Shyr Y, Hunter EB, Olson S, Raiford DS. Hepatic stellate activation in nonalcoholic steatohepatitis and fatty liver. Hum Pathol. 2000 Jul;31(7):822-8. (Pubitemid 30480453)
45. Lowes KN, Groager EJ, Olynyk JK, Abraham LJ, Yeoh GC. Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J Gastroenterol Hepatol. 2003 Jan;18(1):4-12. (Pubitemid 36062580)
46. Park DY, Suh KS. Transforming growth factor-beta1 protein, proliferation and apoptosis of oval cells in acetylaminofuorene-induced rat liver regeneration. J Korean Med Sci. 1999 Oct;14(5):531-8.
47. Yin L, Lynch D, Sell S. Participation of different cell types in restitutive response of the rat liver to periportal injury induced by allyl alcohol. J Hepatol. 1999 Sep;31(3):497-507. (Pubitemid 29408734)
48. Yin L, Lynch D, Sell S. Proliferation and differentiation of ductular progenitor cells and littoral cells during the regeneration of the rat liver to CCI3/2-AAF injury. Histol Histopathol. 2002 Jan;17(1):65-81. (Pubitemid 34116410)
49. Zhang W, Chen XP, Zhang WG, Zhang F, Xiang S, Dong HH, Zhang L. Hepatic-non parenchymal cells and extracellular matrix participate in oval cell-mediated liver regeneration. World J Gastroenterol. 2009 Feb;15(5):552-60.
50. Wang P, Liu T, Cong M, Wu X, Bai Y, Yin C, An W, Wang B, Jia J, You H. Expression of extracellular matrix genes in cultured hepatic oval cells: origin of hepatic stellate cells through transforming growth factor beta? Liver Int. 2009 April;29(4):575-84.
51. Evarts RP, Nakatsukasa H, Marsden ER, Hu Z, Thorgeirsson SS. Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol Carcinog. 1992 Jan;5(1):25-31.
52. Rudolph KL, Trautwein C, Kubicka S, Rakemann T, Bahr MJ, Sedlaczek N, Schuppan D, Manns MP. Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats. Hepatology. 1999 Nov;30(5):1159-66. (Pubitemid 29510853)
53. Tsutsumi K, Nakayama H, Sakai Y, Kojima Y, Dairaku N, Ojima T, Kusano M, Ikeya S, Sugai Y, Hiwatashi N. Two cases of patients with hepatocellular carcinoma (HCC) that developed in cryptogenic cirrhosis suggestive of nonalcoholic steatohepatitis (NASH) as background liver disease after clinical courses of 26 years. Nippon Shokakibyo Gakkai Zasshi. 2007 May;104(5):690-7. (Pubitemid 46933080)